Shelton Capital Management Pacira Bio Sciences, Inc. Transaction History

Shelton Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$51.49 - $81.64 $147,158 - $233,327	-2,858 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$60.03 - $76.49 $171,565 - $218,608	2,858 New	2,858 $218,000
Q2 2021 Aug 12, 2021	SELL	$59.18 - $69.99 $169,136 - $200,031	-2,858 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$59.31 - $78.82 $169,507 - $225,267	2,858 New	2,858 $200,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

Stay updated on Shelton Capital Management with notifications on news.